O'Hara Elaine (CIK 1968045) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy NVAX (56,334 shares), Sell NVAX (22,429 shares), Buy NVAX (19,600 shares), Sell NVAX (5,375 shares), Buy NVAX (40,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Buy | 56,334 | $0 |
| 2026-03-05 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Sell | 22,429 | $212,851 |
| 2026-03-03 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Buy | 19,600 | $0 |
| 2026-03-03 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Sell | 5,375 | $54,502 |
| 2026-03-03 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Buy | 40,000 | $0 |
| 2026-03-03 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Sell | 10,969 | $111,226 |
| 2025-03-04 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Buy | 19,600 | $0 |
| 2025-03-04 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Buy | 40,000 | $0 |
| 2025-03-04 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Sell | 5,375 | $44,774 |
| 2025-03-04 | NOVAVAX INC (NVAX) | EVP, Chief Strategy Officer | Sell | 10,969 | $91,372 |
Source: SEC Form 4 filings · as of 2026-03-05